Cargando…

Misonidazole enhancement of acute and late radiation injury to the rat spinal cord.

Detalles Bibliográficos
Autor principal:	Yuhas, J. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1979
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009967/ https://www.ncbi.nlm.nih.gov/pubmed/454561

Ejemplares similares

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Does misonidazole enhance radiation injury to the central nervous system?
por: Field, S. B., et al.
Publicado: (1981)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
por: Rostom, A. Y., et al.
Publicado: (1978)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Effect of local hyperthermia on the acute toxicity of misonidazole in mice.
por: Overgaard, J.
Publicado: (1979)

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.
por: Rose, G. P., et al.
Publicado: (1980)

Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
por: Siemann, D. W.
Publicado: (1982)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
por: Mulcahy, R. T., et al.
Publicado: (1984)

Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
por: Murray, D., et al.
Publicado: (1983)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
por: Mahood, J. S., et al.
Publicado: (1981)

Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
por: Conroy, P. J., et al.
Publicado: (1980)

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
por: Horsman, M. R., et al.
Publicado: (1984)

Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
por: McNally, N. J., et al.
Publicado: (1983)

A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.
por: Abratt, R. P., et al.
Publicado: (1991)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
por: Smith, E., et al.
Publicado: (1982)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

Interactions between misonidazole and hyperthermia in EMT6 spheroids.
por: Morgan, J. E., et al.
Publicado: (1981)

Enhanced Motor Function by Training in Spinal Cord Contused Rats Following Radiation Therapy
por: Ichiyama, Ronaldo, et al.
Publicado: (2009)

Role of melatonin in the dynamics of acute spinal cord injury in rats
por: Bi, Jiaqi, et al.
Publicado: (2021)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_gjjkmi0u1fkuaaft35gj5ruf56